Moderna, Inc.
MRNA
Market Cap$9.92B
Volume792.05K
Revenue$3.08B
Gross Profits$-2.20B
Employees5800
About
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influe...